These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32008664)

  • 21. Ocular Involvement in Congenital Infections - TORCH.
    Thurau S
    Klin Monbl Augenheilkd; 2023 Oct; 240(10):1174-1178. PubMed ID: 37871592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom.
    Abdel-Fattah SA; Bhat A; Illanes S; Bartha JL; Carrington D
    Prenat Diagn; 2005 Nov; 25(11):1028-31. PubMed ID: 16231309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infective diseases during pregnancy and their teratogenic effects.
    Chiodo F; Verucchi G; Mori F; Attard L; Ricchi E
    Ann Ist Super Sanita; 1993; 29(1):57-67. PubMed ID: 8129273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for infectious diseases.
    Gerber S; Hohlfeld P
    Childs Nerv Syst; 2003 Aug; 19(7-8):429-32. PubMed ID: 12811485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound indications for maternal STORCH testing in pregnancy.
    Voekt CA; Rinderknecht T; Hirsch HH; Blaich A; Hösli IM
    Swiss Med Wkly; 2017; 147():w14534. PubMed ID: 29185251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of infection during pregnancy on fetal development.
    Adams Waldorf KM; McAdams RM
    Reproduction; 2013; 146(5):R151-62. PubMed ID: 23884862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nationwide survey of mother-to-child infections in Japan.
    Yamada H; Tairaku S; Morioka I; Sonoyama A; Tanimura K; Deguchi M; Nagamata S; Ebina Y
    J Infect Chemother; 2015 Mar; 21(3):161-4. PubMed ID: 25435331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of toxoplasma gondii, rubella virus, cytomegalovirus herpes simplex virus (TORCH) and syphilis in Jamaican pregnant women.
    Prabhakar P; Bailey A; Smikle MF; McCaw-Binns A; Ashley D
    West Indian Med J; 1991 Dec; 40(4):166-9. PubMed ID: 1664562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral Infections and the Neonatal Brain.
    de Vries LS
    Semin Pediatr Neurol; 2019 Dec; 32():100769. PubMed ID: 31813517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond TORCH: A narrative review of the impact of antenatal and perinatal infections on the risk of disability.
    Devaraju M; Li A; Ha S; Li M; Shivakumar M; Li H; Nishiguchi EP; Gérardin P; Waldorf KA; Al-Haddad BJS
    Neurosci Biobehav Rev; 2023 Oct; 153():105390. PubMed ID: 37708918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parvovirus B19 infection during pregnancy and risks to the fetus.
    Ornoy A; Ergaz Z
    Birth Defects Res; 2017 Mar; 109(5):311-323. PubMed ID: 28398685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rubella transmitted to placenta and fetus].
    Frischman B; Fogel A; Handscher R; Rikover M
    Harefuah; 1972 Jun; 82(11):512-3. PubMed ID: 4341620
    [No Abstract]   [Full Text] [Related]  

  • 33. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
    Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
    BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congenital Viral Infection: Traversing the Uterine-Placental Interface.
    Pereira L
    Annu Rev Virol; 2018 Sep; 5(1):273-299. PubMed ID: 30048217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody prevalence to torch agents in pregnant women and relative risk of congenital infections in Italy (Liguria).
    Canessa A; Pantarotto F; Miletich F; Russo A; Gotta C; Bozzuffi PM; Ferrari G; Fiorelli A; Terragna A
    Biol Res Pregnancy Perinatol; 1987; 8(2 2D Half):84-8. PubMed ID: 2827796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
    Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction.
    Yamamoto R; Ishii K; Shimada M; Hayashi S; Hidaka N; Nakayama M; Mitsuda N
    J Obstet Gynaecol Res; 2013 Mar; 39(3):653-7. PubMed ID: 23107457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in awareness and knowledge concerning mother-to-child infections among Japanese pregnant women between 2012 and 2018.
    Suga S; Fujioka K; Nakasone R; Abe S; Fukushima S; Ashina M; Nishida K; Nozu K; Iijima K; Tanimura K; Yamada H
    PLoS One; 2021; 16(1):e0244945. PubMed ID: 33406131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Embryonic malformations in a case of intrauterine parvovirus B19 infection.
    Hartwig NG; Vermeij-Keers C; Van Elsacker-Niele AM; Fleuren GJ
    Teratology; 1989 Mar; 39(3):295-302. PubMed ID: 2543097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nationwide survey of maternal screening for mother-to-child infections in Japan.
    Yamada H; Tairaku S; Morioka I; Ebina Y; Sonoyama A; Tanimura K; Deguchi M; Nagamata S
    Congenit Anom (Kyoto); 2014 May; 54(2):100-3. PubMed ID: 24330048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.